Quote:

---

I am excited for this interview. The open ended timing is interesting to me, as it seems to line up with the potential release of mild to moderate data.

---

That could certainly be a possibility.

It might also be possible that Dr.BP is aware that the peer reviewed manuscript is going to be published either this week or next week, and he can discuss his findings in greater detail after that event has happened.

This would be my strong preference as presenting the P2 M/M data to the FDA, along with Dr.BP’s peer reviewed manuscript that explicitly describes leronlimab’s MOA in exquisite detail, is precisely the one-two punch that might tilt the scales for these two statistically low powered trials.

Of course, neither of these may be true and maybe Dr.Been simply asked Dr.NP last Saturday if he could contact Dr.BP to see if he'd appear on the YouTube channel.